Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy.
-
UDIBI
admin_udibi3, , 2023, Sin categorizar, 0
Efficacy, Pharmacokinetics, and Toxicity Profiles of Broad Anti-SARS-CoV-2 Neutralizing Antibody. VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Fecha de publicación: 2 abril de 2020 Development and Evaluation of a Set of Spike and Receptor Binding Domain‐Based...
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Fecha de publicación: 27 de febrero de 2023 Discovery and Optimization of Neutralizing SARS-CoV-2 Antibodies Using ALTHEA Gold Plus...
-
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Fecha de publicación: Marzo 2021 Poor survival in COVID-19 associated with Lymphopenia and Higher Neutrophile-Lymphocyte ratio Ver más
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Validation of a cell-based colorimetric reporter gene assay for the evaluation of Type I Interferons. VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Validation of a cell proliferation assay to assess the potency of a Dialyzable Leucocyte Extract intended for batch release....
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Fecha de publicación: 20 Septiembre 2019 Utilization of naproxen by Amycolatopsis sp. Poz 14 and detectionof the enzymes involved...